This sample expert has over 25 years of experience in the pharmaceutical industry. Co-founds and manages start-up biotech companies. This expert is a founder and Chief Scientific Officer of a pharmaceutical company that develops novel treatments for osteoporosis in addition to being a CEO for a company that develops a novel treatment for ulcerative colitis and mucositis.
Previous to directing a cardiovascular group, this expert was a Senior Scientist responsible for leading cardiovascular drug discovery teams at Merck Research Laboratories and Smith Kline & French. Primary field of research was focused on platelet and coagulation activation in thrombosis and the development of effective new therapies. He has been an adjunct associate professor since 1992 and has been a Special Government Employee (SGE, Grade 15, Step 10) FDA/CDER-CV since 2009.